Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis

NCT00373516 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Vehicle (Placebo) applied BID
DRUG: QRX-101 75 mcg/g ointment applied QD
DRUG: QRX-101 75 mcg/g ointment applied BID

Sponsor

QuatRx Pharmaceuticals Company